Showing results (181-190 of 267) with videos related to
Sort By:
Pageof 27
Chemotherapy|May 24, 2014
Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of feasibility and rates of pathologic complete responsePeter Kern, Anne Kalisch, Hans-Christian Kolberg, et al.Cancers|August 7, 2021
Image-Based Identification and Genomic Analysis of Single Circulating Tumor Cells in High Grade Serous Ovarian Cancer PatientsCarolin Salmon, Janina Levermann, Rui P L Neves, et al.Breast Cancer Research : BCR|March 4, 2005
High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcomeKlaus Jürgen Schmitz, Florian Grabellus, Rainer Callies, et al.Scientific Reports|March 26, 2025
Thymidine kinase 1 concentration and activity in metastatic breast cancer under CDK4/6 inhibitor therapyStefanos Ioannis Moukas, Merle Dohn, Catrin Lehnerdt, et al.European Journal of Endocrinology|December 3, 2005
Clinical and psychological correlates of quality-of-life in polycystic ovary syndromeSusanne Hahn, Onno E Janssen, Susanne Tan, et al.Maturitas|October 28, 2011
Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trialPiero Sismondi, Rainer Kimmig, Ernst Kubista, et al.Archives of Gynecology and Obstetrics|February 27, 2024
High serum levels of leucine-rich α-2 glycoprotein 1 (LRG-1) are associated with poor survival in patients with early breast cancerAndy Göbel, Tilman D Rachner, Oliver Hoffmann, et al.Gynecologic Oncology|May 19, 2009
Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)Werner Meier, Andreas du Bois, Alexander Reuss, et al.International Journal of Cancer|May 21, 2005
Immunotherapy of malignant ascites with trifunctional antibodiesMarkus M Heiss, Michael A Ströhlein, Michael Jäger, et al.Journal of Cancer Research and Clinical Oncology|April 22, 2021
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancerTilman D Rachner, Sabine Kasimir-Bauer, Andy Goebel, et al.Pageof 27